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Objective. The aim of this study was to quantify the presence of Langerhans cells (LC) in oral lichen planus (OLP) and oral
lichenoid lesions (OLL), comparing them with normal epithelium.
Study Design. Thirty-six patients with biopsy-proven OLP or OLL were selected for the study, as well as 23 control subjects
free of inflammatory conditions. Immunohistochemical reactions were performed using the streptavidin-biotin peroxidase
complex method with CD1a and CD83 primary antibodies. Densities were compared between groups and correlated with
microscopic findings.
Results. Patients with lichenoid conditions (OLP  OLL) presented higher densities of CD1a cells than the control subjects
(P  .03). Higher densities of CD1a were associated with a thinner layer of inflammatory cells (P  .02).
Conclusions. This study indicates that OLP and OLL are characterized by the recruitment of LC, which may play a significant
role on its pathogenesis. (Oral Surg Oral Med Oral Pathol Oral Radiol 2012;113:661-666)Lichen planus is a mucocutaneous inflammatory pro-
cess that is characterized histologically by basal kera-
tinocyte damage and interface lymphocyte reaction.
Analysis of the T-lymphocyte infiltrate suggests that
activated cytotoxic T cells may trigger apoptosis of
epithelial cells, using several mechanisms involving,
among others, tumor necrosis factor , CD95L, and
granzyme-B–perforin.1-3 Before T cells can become
activated, Langerhans cells (LC) must process antigen-
derived peptides and present them together with major
histocompatibility complex molecules to T cells.4 In
addition, many agents have been implicated to explain
cytotoxic lymphocyte activation, including dental ma-
terials, drugs, and microorganisms, although no conclu-
sive evidence has clearly linked lichen planus to a
specific antigen.5
Studies analyzing LC in lichen planus found that
they are altered in number; suggesting that they may
play a role in the pathogenesis of this process.6,7
A better understanding of the distribution of den-
dritic cell subsets in oral lichen planus (OLP) may
shed light on its pathogenesis and lead to new strat-
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paring, quantitatively, the LC present in the oral
mucosa of patients diagnosed with OLP and oral
lichenoid lesions (OLLs) compared to healthy con-
trol subjects.
MATERIALS AND METHODS
Patient population
Thirty-six patients with biopsy-proven OLP (n  27)
or OLL (n  9) treated at the Oral Medicine Unit,
University of Campinas, Brazil, were selected for the
study. Inclusion in the study was based on the clin-
icopathologic diagnostic criteria of van der Meij
et al. 2003.8 In summary, patients presented both
typical clinical and microscopic features to be diag-
nosed with OLP. All patients were followed for 6
months and reexamined. The control group com-
prised tongue biopsies collected from 23 patients
who died of noninflammatory diseases and showed
no histologic alterations, as previously described.9
All of the control group samples were obtained
Statement of Clinical Relevance
The study reports a higher concentration of Lang-
erhans cells (LC) in oral lichenoid conditions and a
positive correlation between density of LC and se-
verity of inflammatory response, suggesting a po-
tential role for LC in the pathogenesis of oral li-
chenoid lesions.661
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the Center of Health Sciences, Pernambuco Federal
University, approved the study according to Brazil-
ian law and the Helsinki Statement.
Histopathologic and immunohistochemical
analysis
Selection of biopsy site in the patient group was
based on the presence of the lesion; striated areas
were selected when present at the lateral border of
the tongue or buccal mucosa. The lateral border
of the tongue was the biopsy site in the control group.
The specimens were fixed in 10% formalin and pro-
cessed for routine light microscopy and immunohis-
tochemical analysis. Immunohistochemical reactions
were performed using the streptavidin-biotin perox-
idase complex method with the primary antibodies
CD1a (clone 010, 1:80; Dako) and CD83 (clone
1H4b, 1:20; Novocastra). Antigen retrieval with ci-
trate was performed for both antibodies. The slides
were incubated with secondary antibodies conju-
gated with horseradish peroxidase (LSAB  System-
HRP, Mouse/Rabbit; Dako) for 30 minutes at 37°C.
After that, the slides were incubated with streptavi-
din-HRP (Dako) for another 30 minutes and devel-
oped with chromogenic substrate (3,3-diaminobenzi-
dine; Sigma). The slides were counterstained with
Harris hematoxylin. Negative control samples were
performed for each reaction by omitting the primary
antibodies.
Inflammatory infiltrate depth, acanthosis, and ep-
ithelial atrophy were measured in 3 regions, and the
mean value determined, with the use of a light mi-
croscope connected to a computer with the Leica
Application Suite software. Quantification of LC was
performed in all specimens with the use of a light
microscope (Carl Zeiss) with a 40 and 8 reticu-
lated squared eyepiece (Reichert) having a length of
150 m and area 22.500 m2. Positive cells were
counted for each of the antibodies and the results
expressed as positive cells per area of epithelium in
mm2. Lesional tissues were evaluated in the inflam-
matory associated area and in the adjacent micro-
scopically normal area (internal control).
Statistical analysis
Comparison among groups was performed by anal-
ysis of variance or Student t test with unequal vari-
ances. Spearman rank correlation was used to corre-
late CD1a and CD83 densities with the morphologic
findings. A P value of .05 was regarded to be
statistically significant. Computations were done by
means of the statistical software NCSS 2000.RESULTS
Patient population
Control group. Fourteen patients (61%) were male
and 9 (39%) were female. The male:female ratio was
1.55:1. The average age was 66  12 years (ranging
from 49 to 94 years).
OLP and OLL. The disease sample comprised 26
female patients (72.2%) and 10 male patients (27.18%).
The female:male ratio was 2.6:1. The average age was
52.92  11.65 years (ranging from 28 to 82 years).
OLP was more frequently diagnosed (27 patients, 75%)
than OLL (9 cases, 25%).
Microscopic findings
The mean depth of inflammatory infiltrate for the OLP
group was 0.479  0.174 mm (median 0.456 mm) and
for the OLL group 0.764  0.914 mm (median 0.463
mm; P .18). Acanthosis was higher in OLP (0.425
0.205 mm) than in OLL (0.393  0.137; P  .16)
specimens, and epithelial atrophy was also more in-
tense in OLP (0.099  0.043) than in OLL (0.116 
0.051; P  .21).
LC quantification
The data are summarized in Table I. Patients with
OLP (276.54  85.17/mm2) and OLL (279.36 
143.08/mm2) presented a tendency of higher densi-
ties of CD1a cells than the control subjects (223.60 
93.08/mm2; P  .14). Nevertheless, both disease
groups combined (271.29  102.14/mm2) showed a
statistically significant difference compared with
control subjects (P  .03) and internal controls (P 
.04; Figure 1). CD1a densities did not differ between
OLP and OLL patients (P  .34; Figure 2, A, B, and
C), and CD83 densities were higher in OLL (82.53 
41.10) than in control subjects (63.48  56.66) and
OLP (46.79  19.39) (P  .07; Figure 2, D, E, and
F). CD83 densities were not different from control
subjects, even when both groups were combined
(53.02  29.79) (P  .20). Nevertheless, CD83
densities were higher than internal control (44.20 
Table I. Expression of Langerhans cell–associated an-
tigens in the epithelium of OLP, OLL, and nomal
mucosa (control)
CD1a CD83
OLP 276.54  83.57 46.79  18.94
OLL 284.30  114.43 74.77  42.41
Internal control 230.66  91.26 44.20  20.11
Control 223.65  91.03 63.49  55.42
The numbers are expressed as mean  SEM positive cells per
mm2 of tissue. OLP, Oral lichen planus; OLL, oral lichenoid
lesions.20.11; P  .02). Higher levels of CD1a cells were
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(P  .05), and a mild correlation was observed
among these variables (r  .36; P  .02).
DISCUSSION
This study aimed to evaluate the distribution and
concentration of LC in OLP and OLL and demon-
strated that a significant increase of these cells is
observed compared with noninflamed adjacent tissue
and normal mucosa. LC have an important role in
antigen-processing activity and subsequent presenta-
tion to T cells. Their location in the dermoepithelial
junction, together with their higher number in OLP
and OLL, suggests that they may play a significant
role in the adaptative immune response of lichenoid
conditions.
LC may greatly vary in oral epithelium, and even
adjacent regions of the same organ may show distinct
variances amount of LC. Gondak et al.10 evaluated 4
portions of the tongue (anterior, medium, posterior,
and lateral) and noted a significant variation of LC
concentration even in morphologically healthy epi-
thelium. In addition, several factors can significantly
increase LC concentration in oral epithelium. Infec-
tious diseases, such as gingivitis, periodontitis, and
candidiasis favor an increase of LC in the epithelium,
as well as inflammatory conditions, such as chronic
graft-versus-host-disease.11-13 The latter seems to be
associated with an alloreactive phenomenon induc-
ing a predominantly lymphocytic inflammatory pro-
cess, which may stimulate the secretion of chemo-
kines and chemical attraction of hematopoietic
precursors of LCs from the transplanted bone mar-
Figure 1. Box plot of CD1a cell number according to con-
trol and disease groups, pointing to an increased density of
Langerhans cells in the disease group (P  .03). OLP, Oral
lichen planus; OLL, oral lichenoid lesions.row. On the other hand, human immunodeficiencyvirus seems to be capable of reducing LC recruitment
even in the presence of infectious diseases.9
The present results showed a statistically signifi-
cant increase of CD1a cells /mm2 in the buccal
mucosa of patients who developed OLP and OLL
compared with healthy subjects. In addition, CD83
was higher in OLL specimens compared with OLP
and control samples. Furthermore, we observed an
intense juxtaepithelial lymphocytic inflammatory in-
filtrate in the buccal mucosa associated with OLP. By
analogy with other mucocutaneous inflammatory dis-
eases, such as allergic nasal polyps, allergic contact
dermatitis, psoriasis, and lupus erythematosus,14-16
this study demonstrates that LC are recruited in the
epithelium of OLP/OLL. Also, it can be suggested
that density of CD1a cells is associated with the
severity of inflammatory response, thus regulating
this phenomenon.
During maturation, LCs change from an immature
phenotype characterized by high expression of CD1a
and langerin cell surface molecules and low expression
of CD83 molecules into a mature phenotype character-
ized by down-regulation of CD1a and langerin cell
surface molecules and up-regulation of co-stimulating
molecules CD80, CD83, and CD86.6,17 Thus, it can be
suggested that the lack of differential expression of
CD83 LC among lichenoid diseases and healthy mu-
cosa and the higher presence of CD1a LC in the
disease group possibly correspond to the presence of
immature cells regulating the immune process. Never-
theless, increased CD83 in OLL may suggest the par-
ticipation of mature/activated antigen-presenting cells
in this condition, possibly characterizing a distinctive
reactive phenomenon similar to other inflammatory cu-
taneous diseases.18
A possible explanation for the significant increase
of LC in OLP/OLL, as observed in the present study,
would be the production of specific chemokines for
recruiting precursors of donor LC from the bone
marrow. Initially, an alloreactive phenomenon of the
donor’s T-cells against the host’s persistent LC may
induce a predominantly lymphocytic inflammatory
process, as observed in murine skin.19-22 This in-
flammatory response may stimulate the secretion of
chemokines and consequently establish a local gra-
dient, resulting in the chemical attraction of hema-
topoietic precursors of LC. In this context, activin A
is a protein abundantly produced in the skin during
wound healing23,24 and in inflammatory/autoimmune
diseases that may induce the differentiation of human
CD14 monocytes in langerin, Birbeck granule,
E-cadherin, CLA, and CCR6 cells.25 In addition,
the occurrence of in situ proliferation of LC, as
observed in human and murine skin, can not be
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the chimerism of LCs through 2 pathways: by dimin-
ishing the receptor’s LC through the induction of
apoptosis, and stimulating, on the skin or mucosa,
the production of inflammatory cytokines, which de-
termine the recruitment of precursors of LC from the
donor’s bone marrow.27,28
Deguchi et al.27 reported increased frequency of
epidermal and dermal CD1a LC in skin lichen
planus compared with healthy control skin, but no
significant increase in CD68 macrophages. In fact,
there may be an increased number of CD1a LC in
OLP epithelium,29-31 similarly to the present results.
Figure 2. Immunostaining of CD1a and CD83 in OLP, OL
cells in OLP (A) and OLL (B), which is higher than contr
cells in OLP (D) compared with OLL (E). Control shows
in Figure 1.Interestingly, OLL of patients positive to amalgamallergic patch test present higher number of LC com-
pared with negative patch test OLL patients, rein-
forcing the role of LC in this condition.32 In fact, LC
number seems to be similarly higher in oral lichenoid
conditions, including OLP, OLL, and graft-versus-
host disease and may not discriminate them.30,33
Nevertheless, the role of CD83 mature LC may be
further clarified. It seems that it can characterize
OLL as a distinctive phenomenon with pathogenesis
similar to OLP. This suspicion is reinforced by the
higher presence of lymphoid follicle-like aggregates
in OLL (data not shown). These structures were
observed in 55.6% of the OLL specimens and only
control groups (200). Similar density of CD1a-positive
. CD83 immunostaining show a lower density of positive
low density of CD83-positive cells (F). Abbreviations asL, and
ol (C)
a very7.7% OLP specimens, suggesting the presence of a
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response in such cases.34
In conclusion, the present study indicates that OLP and
OLL are characterized by the recruitment of LC. The
former is also associated with the presence of mature LC
forming a distinctive inflammatory microenvironment.
Therefore, we can suggest that the presence of the lym-
phocytic inflammatory infiltrate in the buccal mucosa, and
consequently locally generated cytokines, determined a
greater recruitment of LC in patients presented with OLP,
thus increasing their quantity. This cell population, by
means of its secretory products and cell interactions, may
promote the ongoing immune reaction in this inflamma-
tory disease.
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